Notice regarding the opinion of our board of directors regarding shareholder proposals

Notice Concerning Recording of Extraordinary Loss (Impairment Loss)

The Announcement of Changes of Directors and Officers

We have released
a.The Notice of the difference between annual forecast and actual results of consolidated financial statements as of FY2023
b.The Notice of the difference from previous year's results regarding non-consolidated financial statements as of FY2023

Annual Financial Results of Oct. 2023 Term

Obtains Exclusive Distribution Rights in Japan for Vascular Therapy Products in the U.S.

(Correction/Numerical data correction)Correction of the 3rd quarter Financial Results of the Oct.2023 Term [Japanese GAAP](consolidated)